A common dominant-negative COL6A1 pseudo-exon insertion is skippable using splice-modulating oligonucleotides

V. Bolduc, A. Foley, S. Donkervoort, Y. Hu, B. Cummings, M. Lek, A. Sarathy, K. Sizov, H. Degefa, R. Wagener, G. Hennig, E. Hanssen, S. Lamande, F. Muntoni, S. Wilton, D. MacArthur, C. Bonnemann

Research output: Contribution to journalAbstract/Meeting Abstract

Original languageEnglish
Pages (from-to)S177-S177
Number of pages1
JournalNeuromuscular Disorders
Volume27
DOIs
Publication statusPublished - Oct 2017
Event22nd International Annual Congress of the World-Muscle-Society (WMS) - Saint Malo, France
Duration: 3 Oct 20177 Oct 2017

Cite this

Bolduc, V., Foley, A., Donkervoort, S., Hu, Y., Cummings, B., Lek, M., Sarathy, A., Sizov, K., Degefa, H., Wagener, R., Hennig, G., Hanssen, E., Lamande, S., Muntoni, F., Wilton, S., MacArthur, D., & Bonnemann, C. (2017). A common dominant-negative COL6A1 pseudo-exon insertion is skippable using splice-modulating oligonucleotides. Neuromuscular Disorders, 27, S177-S177. https://doi.org/10.1016/j.nmd.2017.06.304